Concepedia

Publication | Closed Access

Injectable Paromomycin for Visceral Leishmaniasis in India

DOI

460

Citations

23

References

2007

Year

Shyam Sundar, T. K. Jha, Chandreshwar Prasad Thakur, Prabhat Kumar Sinha, Sujit Bhattacharya
New England Journal of Medicine

Abstract

Paromomycin was shown to be noninferior to amphotericin B for the treatment of visceral leishmaniasis in India. (ClinicalTrials.gov number, NCT00216346.)

References

YearCitations

Page 1